Patents-Review.com
ClassID:

111340 ⎘

C12N2770/24234 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Flaviviridae; Hepacivirus, e.g. hepatitis C virus, hepatitis G virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260078172
2026-03-19

HCV ANTIGENS AND ANTIBODIES

 #2
20260015593
2026-01-15

VSV VECTOR-ENCODED HCV ENVELOPE PROTEINS E1/E2 AS VACCINES AGAINST HEPATITIS C VIRUS

 #3
20250339513
2025-11-06

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

 #4
20250215048
2025-07-03

ASSEMBLED GLYCOPROTEINS

 #5
20250136643
2025-05-01

HEPATITIS C VIRUS E1/E2 HETERODIMERS AND METHODS OF PRODUCING SAME

 #6
20250032606
2025-01-30

POLYVALENT VACCINES AND METHODS FOR MAKING THEM

 #7
20240398938
2024-12-05

Hepatitis C Virus Peptide Compositions and Methods of Use Thereof

 #8
20240358821
2024-10-31

P7 Containing Nucleoside-modified mRNA-lipid Nanoparticle Lineage Vaccine for Hepatitis C Virus

 #9
20240327801
2024-10-03

EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 4a

 #10
20240316186
2024-09-26

E1E2 HCV VACCINES AND METHODS OF USE

 #11
20240269267
2024-08-15

SYNTHETIC DNA VACCINE IMMUNOGENIC IMPROVEMENTS

 #12
20240252623
2024-08-01

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

 #13
20240189421
2024-06-13

IMMUNOGENIC COMPOSITIONS OF HEPATITIS C VIRUS AND USES THEREOF

 #14
20240150409
2024-05-09

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

 #15
20240058438
2024-02-22

Hepatitis C virus immunogenic compositions and methods of use thereof

 #16
20230310590
2023-10-05

Hepatitis C virus immunogenic compositions and methods of use thereof

 #17
20230272350
2023-08-31

METHOD OF PURIFYING WHOLE VIRUS PARTICLES

 #18
20230098265
2023-03-30

E1E2 HCV VACCINES AND METHODS OF USE

 #19
20230034467
2023-02-02

Engineered HCV E2 Immunogens and Related Vaccine Compositions

 #20
20230012022
2023-01-12

CANCER VACCINES AND METHODS OF TREATMENT USING THE SAME

 #21
20220331418
2022-10-20

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

 #22
20220105175
2022-04-07

Hepatitis C virus immunogenic compositions and methods of use thereof

 #23
20220041661
2022-02-10

Hepatitis c virus E1/E2 heterodimers and methods of producing same

 #24
20210386842
2021-12-16

PRIMING OF AN IMMUNE RESPONSE

 #25
20210308242
2021-10-07

Fusion proteins comprising an anti-CD40 antibody and cancer antigens

 #26
20210206812
2021-07-08

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

 #27
20210170018
2021-06-10

Hepatitis C virus immunogenic compositions and methods of use thereof

 #28
20210138063
2021-05-13

HCV vaccines

 #29
20210100895
2021-04-08

Hepatitis C virus immunogenic compositions and methods of use thereof

 #30
20210052721
2021-02-25

Hepatitis C virus peptide compositions and methods of use thereof

 #31
20210024585
2021-01-28

Engineered HCV E2 immunogens and related vaccine compositions

 #32
20200276294
2020-09-03

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

 #33
20200171140
2020-06-04

Compositions and methods for flavivirus vaccination

 #34
20200164061
2020-05-28

Poxviral vaccines

 #35
20200102352
2020-04-02

Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof

 #36
20200085926
2020-03-19

Antigen fused with porcine Fc fragment and vaccine composition comprising the same

 #37
20200054731
2020-02-20

Immunomodulatory compositions and methods of use thereof

 #38
20190284230
2019-09-19

Method for preparing multimeric forms of the hepatitis c virus (HCV) envelope glycoprotein 2 (HCV E2)

 #39
20190231867
2019-08-01

Hepatitis C virus immunogenic compositions and methods of use thereof

 #40
20190224308
2019-07-25

Hepatitis C virus immunogenic compositions and methods of use thereof

 #41
20190209677
2019-07-11

Hepatitis c virus immunogenic compositions and methods of use thereof

 #42
20180282377
2018-10-04

Hepatitis C virus E1/E2 heterodimers and methods of producing same

 #43
20180169219
2018-06-21

Hepatitis C virus immunogenic compositions and methods of use thereof

 #44
20180125968
2018-05-10

Poxviral vaccines

 #45
20180104325
2018-04-19

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

 #46
20180094071
2018-04-05

Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides

 #47
20180057540
2018-03-01

Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof

 #48
20180015156
2018-01-18

POLYMER PARTICLES AND USES THEREOF

 #49
20180000926
2018-01-04

METHODS OF INDUCING AN IMMUNE RESPONSE TO HEPATITIS C VIRUS

 #50
20170333550
2017-11-23

Poxviral vaccines

 #51
20170274067
2017-09-28

Development of methods for production of a whole virus vaccine candidate stock and novel adaptive mutations in hepatitis C virus

 #52
20170224811
2017-08-10

Vaccine adjuvant compositions

 #53
20170216573
2017-08-03

INJECTION NEEDLE AND DEVICE

 #54
20170215393
2017-08-03

Animal models, cell lines and methods for screening hepatitis C virus vaccines

 #55
20170112922
2017-04-27

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

 #56
20170106081
2017-04-20

Cellular vaccine and method of inducing an immune response in a subject

 #57
20170065711
2017-03-09

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

 #58
20170058003
2017-03-02

IMMUNOGEN PLATFORM

 #59
20170043011
2017-02-16

Synthetic hepatitis C polypeptide and methods of making and using same

 #60
20170029470
2017-02-02

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

 #61
20160375129
2016-12-29

Dimeric scaffold peptides comprising HIV-1 GP120 and GP41 epitopes

 #62
20160362454
2016-12-15

Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses

 #63
20160317637
2016-11-03

Immunomodulatory compositions and methods of use thereof

 #64
20160279236
2016-09-29

USE OF RAPAMYCIN AS VACCINE ADJUVANT AND PREPARATION METHOD THEREFOR

 #65
20160244729
2016-08-25

HCV culture systems and direct-acting antiviral sensitivity

 #66
20160229896
2016-08-11

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

 #67
20160215039
2016-07-28

AGENTS AND METHODS BASED ON THE USE OF THE EDA DOMAIN OF FIBRONECTIN

 #68
20160144022
2016-05-26

Modified matrix proteins of vesicular stomatitis virus

 #69
20160030536
2016-02-04

Cancer vaccines and methods of treatment using the same

 #70
20160008459
2016-01-14

Immunogenic polypeptide surface layer-expressing bifidobacterium

 #71
20160000904
2016-01-07

IMPROVED POXVIRAL VACCINES

 #72
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

 #73
20150343089
2015-12-03

Hepatitis C virus liposome vaccine

 #74
20150307558
2015-10-29

Chimeric vaccine antigens against hepatitis C virus

 #75
20150299329
2015-10-22

ANTIGEN PRESENTING CELL TARGETED VACCINES

 #76
20150291684
2015-10-15

Hepatitis C virus neutralizing antibodies and methods

 #77
20150273032
2015-10-01

Regulatory T cell epitope and hepatitis C virus homolog

 #78
20150252084
2015-09-10

COMPOSITIONS AND METHODS THAT ENHANCE AN IMMUNE RESPONSE

 #79
20150216966
2015-08-06

Cellular vaccine and method of inducing an immune response in a subject

 #80
20150166612
2015-06-18

Vaccines and methods for using the same

 #81
20150152392
2015-06-04

HCV full-length infectious cell culture systems and applications thereof

 #82
20150140103
2015-05-21

Isolated nucleic acid for the production of a vaccine against virus

 #83
20150086580
2015-03-26

Rational vaccine design for hepatitis C virus

 #84
20150017207
2015-01-15

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

 #85
20150017197
2015-01-15

HCV vaccines and methods for using the same

 #86
20140348906
2014-11-27

Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes

 #87
20140348866
2014-11-27

Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein

 #88
20140341941
2014-11-20

HIV consensus envelope sequences and methods for using the same

 #89
20140302092
2014-10-09

Mutant replicon derived from genome of hepatitis C virus J6CF strain

 #90
20140302082
2014-10-09

Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 1B, hepatitis C virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis C virus particles

 #91
20140286995
2014-09-25

Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 3a

 #92
20140199763
2014-07-17

Compositions and methods to immunize against hepatitis C virus

 #93
20140186384
2014-07-03

hTERT sequences and methods for using the same

 #94
20140162340
2014-06-12

Synthetic hepatitis C genome and methods of making and use

 #95
20140127198
2014-05-08

Antigen presenting cell targeted anti-viral vaccines

 #96
20140120127
2014-05-01

Recombinant HCV E2 glycoprotein

 #97
20140105931
2014-04-17

Hepatitis C virus particles, vaccines, compositions and methods related thereto

 #98
20140079735
2014-03-20

Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof

 #99
20140044746
2014-02-13

Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes

 #100
20130337002
2013-12-19

Peptide scaffold design

 #101
20130323282
2013-12-05

Compositions and methods

 #102
20130058969
2013-03-07

Chloroplasts engineered to express pharmaceutical proteins

 #103
20130045205
2013-02-21

Methods and compositions related to glycoprotein-immunoglobulin fusions

 #104
20130004529
2013-01-03

HIV consensus envelope sequences and methods for using the same

 #105
20120328651
2012-12-27

Chimpanzee adenovirus vaccine carriers

 #106
20120301465
2012-11-29

COMPOSITIONS AND METHODS TO IMMUNIZE AGAINST HEPATITIS C VIRUS

 #107
20120288510
2012-11-15

Human antibodies against hepatitis C virus (HCV) and uses thereof

 #108
20120251572
2012-10-04

HEPATITIS C VIRUS VACCINE COMPOSITION

 #109
20120208870
2012-08-16

HEPATITIS C VIRUS CODON OPTIMIZED NON-STRUCTURAL NS3/4A FUSION GENE

 #110
20120201846
2012-08-09

POLYMER PARTICLES AND USES THEREOF

 #111
20120177683
2012-07-12

Methods for preparing vesicles and formulations produced therefrom

 #112
20120171230
2012-07-05

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM

 #113
20120135029
2012-05-31

Method for the purification of protein complexes

 #114
20120121537
2012-05-17

Methods and Compositions for Inhibiting Hepatitis C Virus Replication

 #115
20120114746
2012-05-10

Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes

 #116
20120100176
2012-04-26

Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens

 #117
20120100170
2012-04-26

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEPATITIS C

 #118
20120093863
2012-04-19

HCV vaccines and methods for using the same

 #119
20120040367
2012-02-16

CONSTRUCT SYSTEM AND USES THEREFOR

 #120
20120039842
2012-02-16

Compositions and methods that enhance an immune response

 #121
20120034256
2012-02-09

HCV vaccines and methods for using the same

 #122
20120027795
2012-02-02

SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES

 #123
20120027788
2012-02-02

Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof

 #124
20120010394
2012-01-12

Immunogen platform

 #125
20120003719
2012-01-05

Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)

 #126
20110300170
2011-12-08

HCV VACCINES

 #127
20110300169
2011-12-08

Pharmaceutical composition comprising an antigen

 #128
20110293704
2011-12-01

PRIMING OF AN IMMUNE RESPONSE

 #129
20110293656
2011-12-01

RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS

 #130
20110287039
2011-11-24

Expression system for modulating an immune response

 #131
20110280899
2011-11-17

Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes

 #132
20110275139
2011-11-10

Recombinant vaccinia virus having hepatitis C virus gene

 #133
20110274719
2011-11-10

Helicobacter system and uses thereof

 #134
20110256098
2011-10-20

Immunotherapy for chronic hepatitis C virus infection

 #135
20110223185
2011-09-15

CHIMERIC HEPATITIS C VIRUS ANTIGENS FOR ELICITING AN IMMUNE RESPONSE

 #136
20110217332
2011-09-08

Chimpanzee adenovirus vaccine carriers

 #137
20110206711
2011-08-25

METHOD FOR INDUCING CYTOTOXIC T-CELLS, CYTOTOXIC T-CELL INDUCER, AND PHARMACEUTICAL COMPOSITION AND VACCINE EMPLOYING SAME

 #138
20110177110
2011-07-21

COMPOSITIONS COMPRISING CATIONIC MICROPARTICLES AND HCV E1E2 DNA AND METHODS OF USE THEREOF

 #139
20110159039
2011-06-30

ELICITING HCV-SPECIFIC ANTIBODIES

 #140
20110150922
2011-06-23

Immunogen platform

 #141
20110150921
2011-06-23

Fusion proteins and use thereof for preparing hepatitis C vaccines

 #142
20110129498
2011-06-02

VACCINE FOR THE PREVENTION AND THERAPY OF HCV INFECTIONS

 #143
20110110974
2011-05-12

METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN

 #144
20110091495
2011-04-21

HCV E2 CONSTRUCT COMPOSITIONS AND METHODS

 #145
20110082287
2011-04-07

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #146
20110081381
2011-04-07

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #147
20110076304
2011-03-31

ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS

 #148
20110065174
2011-03-17

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #149
20110059513
2011-03-10

Efficient cell culture system for hepatitis C virus genotype 1A and 1B

 #150
20110059512
2011-03-10

Efficient cell culture system for hepatitis C virus genotype 6A

 #151
20110059132
2011-03-10

COMPOSITION FOR THERAPY AND/OR FOR PROPHYLAXIS OF HBV-INFECTIONS AND HBV-MEDIATED DISEASES

 #152
20110045020
2011-02-24

Nucleic acid comprising chimeric gene derived from hepatitis C virus

 #153
20110020374
2011-01-27

Expression system for modulating an immune response

 #154
20110014209
2011-01-20

Recombinant HCV E2 glycoprotein

 #155
20100316669
2010-12-16

Vaccine formulation potentiated by the combination of DNA and an antigen

 #156
20100310605
2010-12-09

ANTI-HCV VACCINE AND PREPARATION METHODS AND USES THEREOF

 #157
20100310586
2010-12-09

Idiotypic vaccine

 #158
20100297170
2010-11-25

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

 #159
20100297114
2010-11-25

Anti-CD40 targeted fusion proteins

 #160
20100292138
2010-11-18

Peptide Derived from Hepatitis C Virus

 #161
20100291130
2010-11-18

CLONED GENOME OF INFECTIOUS HEPATITIS C VIRUS STRAIN HC-TN AND USES THEREOF

 #162
20100291082
2010-11-18

Fusion protein with HIV antigen

 #163
20100278865
2010-11-04

PRODUCTION AND USE OF EPITOPE-TAGGED HEPATITIS C VIRUS PARTICLE

 #164
20100278857
2010-11-04

Dendritic cell binding proteins and uses thereof

 #165
20100247522
2010-09-30

Neutralization of HCV

 #166
20100215696
2010-08-26

EFFICIENTLY REPLICABLE HEPTITIS C VIRUS MUTANT, A HEPTITIS C VIRUS MUTANT COMPRISING REPORTER GENE, A METHOD OF PREPARING OF HCV VACCINE USING THE SAME AND A METHOD OF SCREENING ANTI HCV COMPOSITION USING THE SAME

 #167
20100203074
2010-08-12

COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES

 #168
20100166787
2010-07-01

HPV vaccines and methods for using the same

 #169
20100150963
2010-06-17

Yeast-based therapeutic for chronic hepatitis C infection

 #170
20100143405
2010-06-10

Immunotherapy of virus infection

 #171
20100129913
2010-05-27

POLIOMA VECTOR EXPRESSING LONG DOUBLE-STRANDED RNAS

 #172
20100129901
2010-05-27

Hepatitis C virus vaccine

 #173
20100104592
2010-04-29

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #174
20100104555
2010-04-29

HCV neutralizing epitopes

 #175
20100099613
2010-04-22

PEPTIDES FOR INDUCING A CTL AND/OR HTL RESPONSE TO HEPATITIS C VIRUS

 #176
20100047271
2010-02-25

VACCINE COMPOSITIONS

 #177
20100047264
2010-02-25

Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof

 #178
20100047231
2010-02-25

Immuno-Stimulant Combination for Prophylaxis and Treatment of Hepatitis C

 #179
20100034844
2010-02-11

Activation of HCV specific T cells

 #180
20100034840
2010-02-11

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE TO ESCAPE MUTANTS OF TARGETED THERAPIES

 #181
20100003280
2010-01-07

Adjuvant compositions

 #182
20090297555
2009-12-03

RECOMBINANT HUMAN CYTOMEGALOVIRUS AND VACCINES COMPRISING HETEROLOGOUS ANTIGENS

 #183
20090258033
2009-10-15

HCV E1E2 vaccine compositions

 #184
20090252755
2009-10-08

Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof

 #185
20090238843
2009-09-24

RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS

 #186
20090238822
2009-09-24

Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response

 #187
20090233992
2009-09-17

Hepatitis C virus vaccine

 #188
20090220540
2009-09-03

system and uses thereof

 #189
20090220532
2009-09-03

Agents and methods based on the use of the EDA domain of fibronectin

 #190
20090214593
2009-08-27

IMMUNOGEN PLATFORM

 #191
20090208450
2009-08-20

METHOD FOR ENHANCING THE EFFICACY OF ANTIGEN SPECIFIC TUMOR IMMUNOTHERAPY

 #192
20090196916
2009-08-06

Liposome-mediated ligation

 #193
20090186047
2009-07-23

HCV Vaccinations

 #194
20090186045
2009-07-23

Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants

 #195
20090162317
2009-06-25

Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same

 #196
20090155294
2009-06-18

HCV VACCINES

 #197
20090130135
2009-05-21

HCV VACCINES

 #198
20090104271
2009-04-23

Use of microparticles combined with submicron oil-in-water emulsions

 #199
20090104217
2009-04-23

Pharmaceutical Composition Comprising An Antigen

 #200
20090081246
2009-03-26

METHOD FOR ISOLATING HEPATITIS C VIRUS PEPTIDES

 #201
20090074805
2009-03-19

Yeast-based therapeutic for chronic hepatitis C infection

 #202
20090074803
2009-03-19

Immunogen platform

 #203
20090041836
2009-02-12

Glycolipopeptide antibodies

 #204
20090035277
2009-02-05

Hepatitis C virus nucleic acid vaccine

 #205
20090016993
2009-01-15

MEDICINAL FORMULATION FOR THE TREATMENT FOR HEPATITIS C

 #206
20090010932
2009-01-08

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

 #207
20080311150
2008-12-18

Novel sequences encoding hepatitis C virus glycoproteins

 #208
20080274143
2008-11-06

Chloroplasts Engineering to Express Pharmaceutical Proteins

 #209
20080262211
2008-10-23

Hepatitis-C virus type 4, 5 and 6

 #210
20080260762
2008-10-23

HLA binding motifs and peptides and their uses

 #211
20080241156
2008-10-02

Inhibitors of hepatitis C virus

 #212
20080213290
2008-09-04

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #213
20080145915
2008-06-19

Hepatitis C virus vaccine

 #214
20080138894
2008-06-12

PURIFIED HEPATITIS C VIRUS ENVELOPE PROTEINS FOR DIAGNOSTIC AND THERAPEUTIC USE

 #215
20080138360
2008-06-12

Vaccine Composition Against Hepatitis C Virus

 #216
20080112977
2008-05-15

Supertype Epitopes, Oligonucleotides Coding The Same Which Induce Effective Ctl Response Against Hcv And The Use Thereof

 #217
20080107671
2008-05-08

Yeast-based therapeutic for chronic hepatitis C infection

 #218
20080095800
2008-04-24

Eliciting HCV-specific antibodies

 #219
20080069831
2008-03-20

Yeast-based therapeutic for chronic hepatitis C infection

 #220
20080044384
2008-02-21

Recombinant Human Cytomegalovirus And Vaccines Comprising Heterologous Antigens

 #221
20070280956
2007-12-06

Alternate reading frame hepatitis C virus peptides and uses thereof

 #222
20070275012
2007-11-29

Pharmaceutical Compositions for Therapeutic Use

 #223
20070269460
2007-11-22

Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use

 #224
20070264285
2007-11-15

Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof

 #225
20070160631
2007-07-12

Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes

 #226
20070160630
2007-07-12

Hepatitis-C virus type 4, 5 and 6

 #227
20070134262
2007-06-14

Antigens encoded by alternative reading frames from pathogenic viruses

 #228
20070128721
2007-06-07

Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use

 #229
20070099179
2007-05-03

Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor

 #230
20070065911
2007-03-22

Hepatitis C virus vaccine

 #231
20070055049
2007-03-08

HLA binding motifs and peptides and their uses

 #232
20070048281
2007-03-01

HCV COMBINATION THERAPY

 #233
20070036825
2007-02-15

Flavivirus NS5A proteins for the treatment of HIV

 #234
20070032444
2007-02-08

Genetic immunization with nonstructural proteins of hepatitis C virus

 #235
20070031446
2007-02-08

Hcv vaccines

 #236
20070026425
2007-02-01

Hepatitis C virus non-structural NS3/4A fusion gene

 #237
20060275323
2006-12-07

Particles of HCV envelope proteins: use for vaccination

 #238
20060275322
2006-12-07

Modified HCV peptide immunogens

 #239
20060263386
2006-11-23

Vaccines

 #240
20060222661
2006-10-05

Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins

 #241
20060222629
2006-10-05

Compositions and methods for delivery of genetic material

 #242
20060216691
2006-09-28

Method for isolating hepatitis C virus peptides

 #243
20060183705
2006-08-17

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #244
20060183699
2006-08-17

Vaccines containing ribavirin and methods of use thereof

 #245
20060121448
2006-06-08

Method for inducing complete hepatitis c virus (hcv) replication in vitro

 #246
20060110755
2006-05-25

Yeast-based therapeutic for chronic hepatitis C infection

 #247
20060105365
2006-05-18

Chimeric GB virus B (GBV-B)

 #248
20060093617
2006-05-04

Peptides for inducing a CTL and/or HTL response to hepatitis C virus

 #249
20060069027
2006-03-30

Inhibitors of hepatitis C virus

 #250
20060062801
2006-03-23

Hepatitis C virus non-structural NS3/4A fusion gene

 #251
20060057152
2006-03-16

Helicobacter system and uses thereof

 #252
20060051369
2006-03-09

ADAR1 antiviral pathway

 #253
20060045888
2006-03-02

Antigen library immunization

 #254
20060002896
2006-01-05

Method of generating recombinant MVA

 #255
20050287117
2005-12-29

Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus

 #256
20050281779
2005-12-22

Enhancing immune responses to genetic immunization by using a chemokine

 #257
20050272029
2005-12-08

Hepatitis c viral-like particle purification

 #258
20050266400
2005-12-01

Sequences encoding hepatitis C virus glycoproteins

 #259
20050255124
2005-11-17

HCV E1E2 vaccine compositions

 #260
20050221296
2005-10-06

Hepatitis-C virus type 4, 5 and 6

 #261
20050208143
2005-09-22

Microparticles with adsorbent surfaces, methods of making same, and uses thereof

 #262
20050191319
2005-09-01

Microparticles with adsorbent surfaces, methods of making same, and uses thereof

 #263
20050163797
2005-07-28

Pharmaceutical composition comprising an antigen

 #264
20050136073
2005-06-23

Use of microparticles combined with submicron oil-in-water emulsions

 #265
20050129705
2005-06-16

Modified HCV peptide vaccines

 #266
20050124573
2005-06-09

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #267
20050118181
2005-06-02

GB virus C (hepatitis G virus) for the treatment of HIV

 #268
20050054845
2005-03-10

Thymosin augmentation of genetic immunization

 #269
20050042272
2005-02-24

Vesiles derived from t cells, production and uses

 #270
20050037018
2005-02-17

HCV combination therapy

 #271
20050032047
2005-02-10

Hepatitis-C virus type 4, 5, and 6

 #272
20050019347
2005-01-27

Recombinant mva capable of expressing structural hcv antigens

 #273
17865257
2026-03-17

Transient expression of biologic materials